...
机译:发现7-氧代-2,4,5,7-四氢-6H-吡唑[3,4-C]吡啶衍生物作为有效的,口服和脑穿透受体相互作用蛋白1(RIP1)激酶抑制剂:分析 结构 - 动态关系
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut 10410 Sci Ctr Dr San Diego CA 92121 USA;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut 10410 Sci Ctr Dr San Diego CA 92121 USA;
Takeda Pharmaceut 10410 Sci Ctr Dr San Diego CA 92121 USA;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
Takeda Pharmaceut Co Ltd Res 26-1 Muraoka Higashi 2 Chome Fujisawa Kanagawa 2518555 Japan;
机译:发现7-氧代-2,4,5,7-四氢-6H-吡唑[3,4-C]吡啶衍生物作为有效的,口服和脑穿透受体相互作用蛋白1(RIP1)激酶抑制剂:分析 结构 - 动态关系
机译:N-((1R,2S,5S)-2-{(((5-chloroindol-2-yl)羰基)氨基} -5-(二甲基氨基甲酰基)环己基)-5-甲基-4,5,6, 7-四氢噻唑并(5,4-c)吡啶-2-羧酰胺盐酸盐:一种新颖,有效且口服的Xa因子直接抑制剂。
机译:1-(4-甲氧基苯基)-7-氧代-6-(4-(2-氧代哌啶-1-基)苯基)-4,5,6,7-四氢-1H-吡唑并[3,4-c ] pyridine-3-carboxamide(apixaban,BMS-562247),一种高效,选择性,有效和口服可生物利用的凝血抑制剂
机译:洛叶葡萄球菌毒素衍生物的分子对接分析蛋白酶激酶有效抑制剂
机译:发现吡唑羧酰胺作为有效和选择性的受体相互作用蛋白2(RIP2)激酶抑制剂
机译:校正5-(2,3-二氢-1H-吲哚-5-基)-7H-吡咯的嘧啶-4-胺衍生物作为一种新的受体相互作用蛋白激酶1( RIPK1)抑制剂,其显示在肿瘤转移模型中的有效活性